Monthly Archives: November 2019

http://www.lslog.com/celgene-nabs-fda-approval-for-blockbuster-hopeful-anemia-med-reblozyl/Celgene nabs FDA approval for blockbuster hopeful anemia med Reblozyl

Celgene nabs FDA approval for blockbuster hopeful anemia med Reblozyl

Celgene nabs FDA approval for blockbuster hopeful anemia med Reblozyl Bristol-Myers Squibb’s $74 billion pending pick-up of Celgene has notched a win already with an FDA approval for JAK med […]

http://www.lslog.com/pfizers-brainstorming-payment-deals-as-gene-therapies-advance-exec-tells-bloomberg/Pfizer's 'brainstorming' payment deals as gene therapies advance, exec tells Bloomberg

Pfizer's 'brainstorming' payment deals as gene therapies advance, exec tells Bloomberg

Pfizer’s ‘brainstorming’ payment deals as gene therapies advance, exec tells Bloomberg Gene therapies offer a “world of wonders” for patients, but they present some scientific and manufacturing challenges, a top […]